Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
NYSE COMPOSITE INDX
Gold
Crude Oil
BIOSPECIFICS TEC RG
(NQ:
BSTC
)
43.33
USD
-0.50 (-1.14%)
Streaming Delayed Price
/ Updated:
1:40 PM EDT, Apr 20, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
28,196
Open
43.54
Bid (Size)
42.90 (100)
Ask (Size)
43.36 (400)
Prev. Close
43.83
Today's Range
42.25 - 43.56
52wk Range
38.27 - 58.79
Shares Outstanding
7,199,233
Dividend Yield
N/A
Performance
YTD
-0.69%
-0.69%
1 Month
+1.55%
+1.55%
3 Month
+1.26%
+1.26%
6 Month
-10.60%
-10.60%
1 Year
-20.76%
-20.76%
Top News
More News
New Research: Key Drivers of Growth for Talend S.A, Chipmos Technologies, POSCO, Horizon Pharma Public, BioSpecifics Technologies, and Arbutus Biopharma — Factors of Influence, Major Initiatives and S
April 11, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Talend S.A. (NASDAQ:TLND),...
Read More
from
GlobeNewswire News Releases
New Research: Key Drivers of Growth for CNB Financial, Akebia Therapeutics, Mesoblast, 21Vianet Group, Old Line Bancshares, and BioSpecifics Technologies — Factors of Influence, Major Initiatives and
March 16, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CNB Financial Corporation...
Read More
from
GlobeNewswire News Releases
More News
Read More
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
March 14, 2018
from
PR Newswire
BioSpecifics Technologies Corp. Announces Presentation of Interim Data from Phase 1 Study of CCH for the Treatment of Uterine Fibroids at 65th Annual Scientific Meeting of the Society for Reproductive
March 12, 2018
from
PR Newswire
BioSpecifics Technologies Corp. to Present at the NobleCon14 Conference
January 22, 2018
from
PR Newswire
BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results
November 10, 2017
from
PR Newswire
BioSpecifics Technologies Corp. to Present at the Stifel 2017 Healthcare Conference
November 07, 2017
from
PR Newswire
BioSpecifics Technologies Corp. to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
September 20, 2017
from
PR Newswire
BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences
September 05, 2017
from
PR Newswire
BioSpecifics Technologies Corp. Reports Second Quarter 2017 Financial Results
August 09, 2017
from
PR Newswire
BioSpecifics Technologies Corp. to Present at the Jefferies 2017 Healthcare Conference
June 02, 2017
from
PR Newswire
Stock Market JSON API
provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial